Mineralys Therapeutics (MLYS) Net Income (2022 - 2026)

Quarterly results put Net Income at -$39.3 million for Q1 2026, up 6.79% from a year ago — trailing twelve months through Mar 2026 was -$151.8 million (up 19.48% YoY), and the annual figure for FY2025 was -$154.7 million, up 13.03%.

Mineralys Therapeutics has reported Net Income over the past 5 years, most recently at -$39.3 million for Q1 2026.

  • Net Income reached -$39.3 million in Q1 2026 per MLYS's latest filing, down from -$32.2 million in the prior quarter.
  • Across five years, Net Income topped out at -$6.5 million in Q2 2022 and bottomed at -$56.3 million in Q3 2024.
  • Median Net Income over the past 5 years was -$31.5 million (2024), compared with a mean of -$27.9 million.
  • The largest annual shift saw Net Income tumbled 240.62% in 2023 before it skyrocketed 34.43% in 2025.
  • Over 5 years, Net Income stood at -$9.1 million in 2022, then plummeted by 168.82% to -$24.4 million in 2023, then crashed by 100.73% to -$49.0 million in 2024, then skyrocketed by 34.16% to -$32.2 million in 2025, then dropped by 22.05% to -$39.3 million in 2026.
  • Business Quant data shows Net Income for MLYS at -$39.3 million in Q1 2026, -$32.2 million in Q4 2025, and -$36.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -8.50 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.40 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - -39.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -39.34 Mn
Dec 31, 2025 -32.24 Mn
Sep 30, 2025 -36.94 Mn
Jun 30, 2025 -43.27 Mn
Mar 31, 2025 -42.21 Mn
Dec 31, 2024 -48.96 Mn
Sep 30, 2024 -56.33 Mn
Jun 30, 2024 -41.02 Mn
Mar 31, 2024 -31.51 Mn
Dec 31, 2023 -24.39 Mn
Sep 30, 2023 -22.76 Mn
Jun 30, 2023 -12.14 Mn
Mar 31, 2023 -12.61 Mn
Dec 31, 2022 -9.07 Mn
Sep 30, 2022 -6.68 Mn
Jun 30, 2022 -6.48 Mn
Mar 31, 2022 -7.57 Mn